Crosstalk Identified Between Adipose Tissue, Carcinomas

Share this content:
Crosstalk Identified Between Adipose Tissue, Carcinomas
Crosstalk Identified Between Adipose Tissue, Carcinomas

FRIDAY, Sept. 1, 2017 (HealthDay News) -- There is organ-dependent crosstalk between adipose tissue and carcinomas in various organs, according to a review published in the September issue of Cancer Prevention Research.

Caroline Himbert, from the Huntsman Cancer Institute in Salt Lake City, and colleagues conducted a systematic review to examine the direct crosstalk between adipose tissue and cancer-prone cells in humans. A total of 4,641 articles were identified with 20 human clinical studies (seven breast, four colorectal, two esophageal, one esophageal/colorectal, one endometrial, four prostate, and one ear-nose-throat cancer).

The researchers found that the data from these clinical studies reinforced preclinical data, indicating organ-dependent crosstalk between adipose tissue and carcinomas, involving mechanisms such as vascular epidermal growth factor, interleukin-6, tumor necrosis factor α, and others. A more central role was played by visceral white adipose tissue, which correlated with a more procancer secretome than subcutaneous adipose tissue.

"Efforts to eavesdrop and ultimately interfere with this cancer-enhancing crosstalk may lead to new targets and strategies for decreasing the burden of obesity-related cancers," the authors write.

Several authors disclosed financial ties to the pharmaceutical industry.

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions


Sign up for myCME e-newsletters


More in Home

FDA OKs Nucala for Eosinophilic Granulomatosis With Polyangiitis

FDA OKs Nucala for Eosinophilic Granulomatosis With Polyangiitis

First drug to be approved for rare autoimmune disease that leads to vasculitis

Findings Support Individualized Glycemic Control in T2DM

Findings Support Individualized Glycemic Control in T2DM

Approach saved $13,547/patient vs uniform intensive control, with lower medication costs

Atherosclerosis ID'd in Many Without CV Risk Factors

Atherosclerosis ID'd in Many Without CV Risk Factors

LDL-C independently associated with the presence and extent of atherosclerosis

is free, fast, and customized just for you!

Already a member?

Sign In Now »